Testing effectiveness (Phase 2)Looking for participantsNCT06185673
What this trial is testing
Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
Who this might be right for
Oculopharyngeal Muscular Dystrophy
Benitec Biopharma, Inc. 30